Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Ocrelizumab 300mg | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
| 2 | Ocrelizumab 300mg /10ml | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
| 3 | Ocrelizumab 300mg/10 ml | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
| 4 | Ocrelizumab 300mg/10ml | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |